CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 14 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126 | +687.5% | 141 | +1075.0% | 0.00% | – |
| Q2 2023 | $16 | -97.5% | 12 | -97.1% | 0.00% | – |
| Q1 2023 | $653 | -95.6% | 411 | -91.1% | 0.00% | – |
| Q4 2022 | $14,813 | +23.4% | 4,629 | -5.3% | 0.00% | – |
| Q3 2022 | $12,000 | +200.0% | 4,888 | +452.3% | 0.00% | – |
| Q1 2022 | $4,000 | -69.2% | 885 | -52.0% | 0.00% | – |
| Q4 2021 | $13,000 | -31.6% | 1,845 | +5.4% | 0.00% | – |
| Q3 2021 | $19,000 | +533.3% | 1,751 | +1159.7% | 0.00% | – |
| Q2 2021 | $3,000 | -87.5% | 139 | -83.3% | 0.00% | – |
| Q1 2021 | $24,000 | – | 834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $12,375,000 | 0.20% |
| Ikarian Capital, LLC | 268,104 | $1,292,000 | 0.17% |
| Cormorant Asset Management, LP | 288,168 | $1,383,000 | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,298 | $198,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 35,024 | $167,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $5,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 10,807 | $52,000 | 0.00% |
| JPMORGAN CHASE & CO | 753 | $4,000 | 0.00% |
| Renaissance Technologies | 27,960 | $134,000 | 0.00% |
| ARK Investment Management | 792 | $4,000 | 0.00% |